Description
Adipotide is an innovative experimental peptide developed to target and reduce adipose tissue through a unique mechanism of action. Unlike traditional weight management approaches, Adipotide functions by directly binding to the blood vessels that supply white fat cells, leading to selective apoptosis (programmed cell death) of these fat cells. This targeted activity has positioned Adipotide as a highly interesting research compound in the fields of obesity, metabolic health, and related conditions.
Key Features and Mechanism of Action
-
Selective Fat Reduction – Adipotide is designed to disrupt the blood supply to white adipose tissue, promoting fat cell death without affecting surrounding healthy tissues.
-
Non-Stimulatory Approach – Unlike appetite suppressants or thermogenic agents, Adipotide does not rely on stimulating the central nervous system.
-
Potential for Metabolic Improvement – Preclinical research suggests benefits in improving insulin sensitivity and supporting healthier body composition.
-
Unique Mode of Action – Targets vasculature of fat deposits, making it different from other weight management peptides.
Potential Research Applications
-
Obesity and metabolic disorder models
-
Insulin resistance studies
-
Fat tissue metabolism research
-
Exploring novel anti-obesity therapies
Product Details
-
Format: Lyophilized peptide powder
-
Purity: >98% (third-party tested)
-
Packaging: Secure, sterile, and laboratory-grade vials
-
Storage: Keep frozen at -20°C before reconstitution. After reconstitution, store refrigerated at 2–8°C.
